CALL US NOW (952) 943-3937
DONATE NOW

Tagged as: FDA

committee testimony

FDA Committee Votes Against Approval of New Opioid

On June 26, advocates of the Steve Rummler HOPE Network testified to an FDA panel opposing the approval of a powerful new extended-release opioid, Remoxy™. Executive Director, Lexi Reed Holtum was joined by board member, Michael Daub and medical advisory committee member, Dr. Andrew Kolodny. The FDA advisory committee voted

Read More

NEWSLETTER SIGN-UP

Stay up to date with the Steve Rummler HOPE Network.